Vivos Therapeutics, Inc.
NASDAQ: VVOS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- R. Kirk Huntsman
- Employees
- 105
- Headquarters
- Littleton, United States
- IPO year
- 2020
- Market cap
- $2.6M
- Website
- https://www.vivos.com
Loading VVOS…
Loading profile data…Frequently asked questions about VVOS
What does Vivos Therapeutics, Inc. (VVOS) do?
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the trea...
Where does VVOS trade?
Vivos Therapeutics, Inc. (VVOS) trades on the NASDAQ.
What sector is VVOS in?
Vivos Therapeutics, Inc. (VVOS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Vivos Therapeutics, Inc.?
R. Kirk Huntsman is the chief executive officer of Vivos Therapeutics, Inc. (VVOS).
Where is Vivos Therapeutics, Inc. headquartered?
Vivos Therapeutics, Inc. is headquartered in United States.
Does VVOS pay a dividend?
Vivos Therapeutics, Inc. (VVOS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VVOS go public?
Vivos Therapeutics, Inc. (VVOS) completed its initial public offering in 2020.